Beck Bode LLC’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
Beck Bode LLC's BSX.PRA Position: Q4 2022 in Review
Beck Bode LLC sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q4 2022, closing a stake of 2,424 shares — an estimated $245K sold.
Beck Bode LLC first reported a position in BSX.PRA in Q2 2022 and held it in 2 quarters. The position peaked at $245K in Q3 2022. 57 funds tracked by Wall St. Rank hold BSX.PRA as of Q4 2022.
- Beck Bode LLC reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q4 2022 after selling out during the quarter.
- Beck Bode LLC sold 2,424 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q4 2022, an estimated $245K.
- Beck Bode LLC first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2022 and held it in 2 quarters.
- Beck Bode LLC's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $245K in Q3 2022.
- 57 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q4 2022.
Based on Beck Bode LLC's 13F filing for Q4 2022, filed 8 Feb 2023.